|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 July 2021 |
|
Main ID: |
NCT04948450 |
|
Date of registration:
|
04/06/2021 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Multidomain Intervention Programs for Older People With Dementia With Dementia
|
|
Scientific title:
|
Multidomain Intervention Programs for Older People With Dementia |
|
Date of first enrolment:
|
August 1, 2021 |
|
Target sample size:
|
152 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT04948450 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Vietnam
| | | | | | | |
|
Contacts
|
|
Name:
|
Thanh X Nguyen, Master |
|
Address:
|
|
|
Telephone:
|
+84983277646 |
|
Email:
|
xuanthanh1901vlk@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Nguyen X Thanh, Master |
|
Address:
|
|
|
Telephone:
|
+84983277646 |
|
Email:
|
xuanthanh1901vlk@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Anh T Nguyen, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Geriatric Hospital |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- aged 60-79 years old
- living in the community
- who have a diagnosis of mild-moderate vascular dementia or mixed dementia according to
DSM 5 criteria.
- receiving pharmacological treatment for dementia (cholinesterase inhibitors,
memantine), must be on a stable dose for at least 3 months prior to the study.
- must be able to mobilise independently with or without a mobility aid and without
physical assistance.
- must have a caregiver who either lives with the participant or visits for at least
four hours per week.
Exclusion Criteria:
- acute and malignant diseases (advanced cancers, end-stage chronic diseases, acute
myocardial infarction, stroke)
- Symptomatic cardiovascular disease, coronary revascularization within 1 year
- Clinical evidence of schizophrenia, severe depression, psychiatric or bipolar disorder
(according to DSM-IV TR criteria) [12]
- Alcoholism or substance dependence (according to DSM-5 criteria) [13], currently, or
within the past 2 years
- Severe loss of vision, hearing or communicative ability (according to the interRAI
Community Health Assessment) [14]
- Participant or family unwilling to participate in the study
Age minimum:
60 Years
Age maximum:
79 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Dementia, Mixed
|
|
Dementia, Vascular
|
|
Intervention(s)
|
|
Behavioral: Cognitive stimulation intervention
|
|
Behavioral: Physical activity intervention
|
|
Other: Reduce of metabolic and vascular risk factors
|
|
Primary Outcome(s)
|
|
Cognitive performance
[Time Frame: Change from Baseline Cognitive performance at 12 months]
|
|
Secondary Outcome(s)
|
|
Attention function
[Time Frame: Change from Baseline Attention function at 12 months]
|
|
Behaviours (agitation, aggression)
[Time Frame: Change from Baseline Behaviours at 12 months]
|
|
Caregiver burden
[Time Frame: Change from Baseline Caregiver burden at 12 months]
|
|
Caregiver depression
[Time Frame: Change from Baseline Caregiver depression at 12 months]
|
|
Caregiver quality of life
[Time Frame: Change from Baseline Caregiver quality of life at 12 months]
|
|
Completers
[Time Frame: 12 months]
|
|
Dementia severity
[Time Frame: Change from Baseline Dementia severity at 12 months]
|
|
Excutive function using Clock drawing test
[Time Frame: Change from Baseline Clock drawing test at 12 months]
|
|
Excutive function using Trails B test
[Time Frame: Change from Baseline Trails B test at 12 months]
|
|
Fall risks
[Time Frame: Change from Baseline Fall risks at 12 months]
|
|
Functional ability
[Time Frame: Change from Baseline Functional ability at 12 months]
|
|
Memory function
[Time Frame: Change from Baseline Memory function at 12 months]
|
|
Prevalence of fall
[Time Frame: Change from Baseline Prevalence of fall at 12 months]
|
|
Quality of sleep
[Time Frame: Change from Baseline Quality of sleep at 12 months]
|
|
Secondary ID(s)
|
|
AG064688
|
|
CB1.02
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|